Myocardial protective effect by ulinastatin via an anti-inflammatory response after regional ischemia/reperfusion injury in an in vivo rat heart model
Open Access
- 1 January 2011
- journal article
- Published by The Korean Society of Anesthesiologists in Korean Journal of Anesthesiology
- Vol. 61 (6) , 499-505
Abstract
Ulinastatin has anti-inflammatory properties and protects organs from ischemia/reperfusion-induced injury. The aim of this study was to investigate whether ulinastatin provides a protective effect on a regional myocardial ischemia/reperfusion injury in an in vivo rat heart model and to determine whether the anti-inflammatory response is related to its myocardial protective effect. Rats were randomized to two groups. One group is received ulinastatin (50,000 U/kg or 100,000 U/kg) diluted in normal saline and the other group is received normal saline, which was administered intraperitoneally 30 min before the ischemic insult. Reperfusion after 30 min of ischemia of the left coronary artery territory was applied. Hemodynamic measurements were recorded serially during 6 h after reperfusion. After the 6 h reperfusion, myocardial infarct size, cardiac enzymes, myeloperoxidase activity, and inflammatory cytokine levels were compared between the ulinastatin treated and untreated groups. Ulinastatin improved cardiac function and reduced infarct size after regional ischemia/reperfusion injury. Ulinastatin significantly attenuated tumor necrosis factor-α expression and reduced myeloperoxidase activity. Ulinastatin showed a myocardial protective effect after regional ischemia/reperfusion injury in an in vivo rat heart model. This protective effect of ulinastatin might be related in part to ulinastatin's ability to inhibit myeloperoxidase activity and decrease expression of tumor necrosis factor-α.Keywords
This publication has 23 references indexed in Scilit:
- Ethyl Pyruvate Has Anti-Inflammatory and Delayed Myocardial Protective Effects after Regional Ischemia/Reperfusion InjuryYonsei Medical Journal, 2010
- Propofol has delayed myocardial protective effects after a regional ischemia/reperfusion injury in an in vivo rat heart modelKorean Journal of Anesthesiology, 2010
- Neutrophil activation precedes myocardial injury in patients with acute myocardial infarctionFree Radical Biology and Medicine, 2009
- Biological activities of C1 inhibitorMolecular Immunology, 2008
- Ulinastatin Attenuates Lung Ischemia-Reperfusion Injury in Rats by Inhibiting Tumor Necrosis Factor AlphaTransplantation Proceedings, 2006
- Protective effect of urinary trypsin inhibitor on myocardial mitochondria during hemorrhagic shock and reperfusionCritical Care Medicine, 2003
- Ulinastatin, a protease inhibitor, attenuates hepatic ischemia/reperfusion injury by downregulating TNF-α in the liverTransplantation Proceedings, 1998
- Role of Neutrophils in Myocardial Ischemia and ReperfusionCirculation, 1995
- Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty.Circulation, 1994
- Perioperative Cardiac MorbidityAnesthesiology, 1990